US · Basic Materials · Specialty Chemicals
EPS came in at 0.42 against a street estimate of 0.43 — a miss of 2.3%.
Analysts rate Chemours Co a buy (5 buy, 5 hold, 0 sell out of 10) with an average price target of $19.00.
MIXED Q2 beat EBITDA despite soft aftermarket demand. TSS destocking pressures 2026 outlook. TT pricing strength and APM data-center momentum offer upside. Targeting $1B EBITDA long-term with 40%+ free cash flow conversion. Q2 2026 No geographic breakouts provided; TT noted strength in Asia ex-China and Latin America. TSS residential demand under pressure from higher rates and affordability. Analysts pressed on TSS margin compression (one-quarter vs. structural reset), aftermarket inventory visibility amid fragmented service provider base, and whether OEM strength reconciles with aftermarket slowdown. Management attributed Q2/Q3 weakness to 2025 AIM Act channel-fill comparatives, macro headwinds, and timing of end-customer conversions post-OEM build, expecting recovery in 2027. Street expressed skepticism on magnitude vs. larger competitors' commentary. 2026-08-05…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 14.87% |
| Vanguard Portfolio Management, LLC | 6.86% |
| Vanguard Capital Management, LLC | 4.50% |
| State Street Corp | 4.07% |
| Ameriprise Financial Inc | 3.21% |
| American Century Companies Inc | 2.91% |
| JPMorgan Chase & Co | 2.53% |
| Geode Capital Management, LLC | 2.39% |
| Document | Date |
|---|---|
| Material agreement · Q3 2026 CHEMOURS COMPANY (CC) - FORM 8-K SUMMARY HEADLINE NUMBERS • Settlement Amount: $455 million payable to North Carolina state and 11 local entities ov | 2026-09-10 |
| Reg FD disclosure · Q3 2026 THE CHEMOURS COMPANY – 8-K SUMMARY DOCUMENT TYPE & CONTEXT • This is a Form 8-K current report filed September 9, 2026 by The Chemours Company (ticke | 2026-09-09 |
| Quarterly report · Q2 2026 THE CHEMOURS COMPANY - 10-Q SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Net sales (Q2 2026): $1,591 million vs. $1,615 million in Q2 2025 (down | 2026-08-05 |
| Results announced · Q3 2026 CHEMOURS COMPANY Q2 2026 RESULTS SUMMARY HEADLINE NUMBERS • Net Sales: $1,591 million in Q2 2026, down 1% year-over-year but up 15% sequentially fro | 2026-08-04 |
| Material agreement · Q2 2026 CHEMOURS COMPANY (CC) – 8-K FILING SUMMARY June 23, 2026 --- HEADLINE NUMBERS • Civil penalty: $22.5 million payable in three annual installments s | 2026-06-24 |
| Quarterly report · Q1 2026 CHEMOURS COMPANY (CC) - Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Net sales Q1 2026: $1,381 million vs. $1,368 million Q1 2025 (+0.9% YoY) • Net loss | 2026-05-05 |
| Results announced · Q2 2026 CHEMOURS COMPANY – Q1 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Net Sales: $1,381 million, up 1% year-over-year and up 4% sequentially • Net Loss: $2 | 2026-05-05 |
| Board / officer change · Q2 2026 CHEMOURS COMPANY (CC) - 8-K SUMMARY HEADLINE NUMBERS • Annual shareholder meeting held April 24, 2026 • New 2026 Equity and Incentive Plan approved | 2026-04-30 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.09 / share ex-date Aug 14, 2026 · pay Sep 15, 2026 | 2026-08-14 |
| Dividend | $0.09 / share ex-date May 15, 2026 · pay Jun 16, 2026 | 2026-05-15 |
| Dividend | $0.09 / share ex-date Feb 27, 2026 · pay Mar 13, 2026 | 2026-02-27 |
| Dividend | $0.09 / share ex-date Nov 14, 2025 · pay Dec 15, 2025 | 2025-11-14 |
| Dividend | $0.09 / share ex-date Aug 15, 2025 · pay Sep 12, 2025 | 2025-08-15 |
| Announcement | Date |
|---|---|
| 2026 outlook: 3-5% revenue growth, $800-900M adjusted EBITDA Chemours reported flat full-year 2025 sales ($5.8 billion) with a significant net loss of $386 million ($2.57 per share), down from $69 million net income in 2024. Adjusted earnings fell 20% | 2026-02-19 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Chemours Co — free to start.
Google PlayApp StoreData updated 2026-09-18.